February 1, 2021

“OPHTHALMOS” always pioneer

In 2020, despite the impact of the coronavirus pandemic, Ophthalmos Institute acquired the last generation robotic Excimer Laser. The new “smart” laser treats all refractive errors, myopia, hyperopia, astigmatism and presbyopia without making incisions with surgical instruments but only with the laser beam; meaning a softer intervention and more respect to the eye tissues. The Excelsius laser is designed for maximum patient comfort. Unlike other lasers, the patient lies still and the beam applicator moves towards the patient. Its optics allow for high precision and predictability. A dynamic laser beam delivery follows in full the eye movements during the treatment ensuring excellent optical outcomes. Our results so far are excellent with high patient satisfaction.

Research is also one of Ophthalmos Institute preferential activities. In 2020 we completed a study of 30 patients for the correction of keratoconus with toric ICLs (Implantable Collamer Lens) which will be submitted for publication. Keratoconus is a disorder of the eye that results in progressive thinning of the cornea. This may result in blurry vision, myopia, irregular astigmatism, and light sensitivity leading to poor quality-of-life. Usually both eyes are affected. The Implantable Collamer Lens (ICL) is an advanced, thin, clear lens that functions similarly to a contact lens; however it is surgically implanted into the eye behind the iris and in front of the crystalline lens of the eye. The procedure is quick, safe and the only procedure that is reversible.  These lenses can correct high amount of refractive errors which is the case in Keratoconus. Keratoconic patients after the ICL implantation do not need keratoconic contact lenses which are difficult to fit and can be very uncomfortable and avoid a corneal transplantation is not required in order to restore vision.

Spyros Georgaras
Ophthalmic Surgeon, FEBO
General Manager